nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—pancreatic cancer	0.734	1	CbGaD
Salicylate-sodium—Acetylsalicylic acid—NFKBIA—pancreatic cancer	0.00464	0.456	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—TP53—pancreatic cancer	0.00205	0.202	CrCbGaD
Salicylate-sodium—Mesalazine—PPARG—pancreatic cancer	0.0011	0.109	CrCbGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—pancreatic cancer	0.000632	0.0622	CrCbGaD
Salicylate-sodium—Salsalate—PTGS2—pancreatic cancer	0.000537	0.0529	CrCbGaD
Salicylate-sodium—Mesalazine—PTGS2—pancreatic cancer	0.000466	0.0459	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—pancreatic cancer	0.000401	0.0395	CrCbGaD
Salicylate-sodium—Salicylic acid—PTGS2—pancreatic cancer	0.000331	0.0325	CrCbGaD
Salicylate-sodium—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000326	0.00127	CcSEcCtD
Salicylate-sodium—Oedema—Fluorouracil—pancreatic cancer	0.000326	0.00127	CcSEcCtD
Salicylate-sodium—Anorexia—Irinotecan—pancreatic cancer	0.000324	0.00127	CcSEcCtD
Salicylate-sodium—Infection—Fluorouracil—pancreatic cancer	0.000323	0.00127	CcSEcCtD
Salicylate-sodium—Renal failure acute—Doxorubicin—pancreatic cancer	0.000323	0.00127	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00032	0.00125	CcSEcCtD
Salicylate-sodium—Dizziness—Tamoxifen—pancreatic cancer	0.000319	0.00125	CcSEcCtD
Salicylate-sodium—Tachycardia—Fluorouracil—pancreatic cancer	0.000318	0.00124	CcSEcCtD
Salicylate-sodium—Hypotension—Irinotecan—pancreatic cancer	0.000318	0.00124	CcSEcCtD
Salicylate-sodium—Anorexia—Gemcitabine—pancreatic cancer	0.000316	0.00124	CcSEcCtD
Salicylate-sodium—Dizziness—Erlotinib—pancreatic cancer	0.000315	0.00123	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—pancreatic cancer	0.000314	0.00123	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Docetaxel—pancreatic cancer	0.000313	0.00122	CcSEcCtD
Salicylate-sodium—Anorexia—Fluorouracil—pancreatic cancer	0.00031	0.00121	CcSEcCtD
Salicylate-sodium—Hypotension—Gemcitabine—pancreatic cancer	0.000309	0.00121	CcSEcCtD
Salicylate-sodium—Vomiting—Tamoxifen—pancreatic cancer	0.000306	0.0012	CcSEcCtD
Salicylate-sodium—Paraesthesia—Irinotecan—pancreatic cancer	0.000305	0.00119	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—pancreatic cancer	0.000305	0.00119	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000305	0.00119	CcSEcCtD
Salicylate-sodium—Hypotension—Fluorouracil—pancreatic cancer	0.000304	0.00119	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Sunitinib—pancreatic cancer	0.000304	0.00119	CcSEcCtD
Salicylate-sodium—Rash—Tamoxifen—pancreatic cancer	0.000304	0.00119	CcSEcCtD
Salicylate-sodium—Dermatitis—Tamoxifen—pancreatic cancer	0.000304	0.00119	CcSEcCtD
Salicylate-sodium—Vomiting—Erlotinib—pancreatic cancer	0.000303	0.00119	CcSEcCtD
Salicylate-sodium—Dyspnoea—Irinotecan—pancreatic cancer	0.000303	0.00119	CcSEcCtD
Salicylate-sodium—Somnolence—Irinotecan—pancreatic cancer	0.000302	0.00118	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000302	0.00118	CcSEcCtD
Salicylate-sodium—Headache—Tamoxifen—pancreatic cancer	0.000302	0.00118	CcSEcCtD
Salicylate-sodium—Rash—Erlotinib—pancreatic cancer	0.000301	0.00118	CcSEcCtD
Salicylate-sodium—Dermatitis—Erlotinib—pancreatic cancer	0.0003	0.00118	CcSEcCtD
Salicylate-sodium—Dehydration—Epirubicin—pancreatic cancer	0.0003	0.00117	CcSEcCtD
Salicylate-sodium—Dyspepsia—Irinotecan—pancreatic cancer	0.000299	0.00117	CcSEcCtD
Salicylate-sodium—Headache—Erlotinib—pancreatic cancer	0.000299	0.00117	CcSEcCtD
Salicylate-sodium—Paraesthesia—Gemcitabine—pancreatic cancer	0.000297	0.00116	CcSEcCtD
Salicylate-sodium—Asthenia—Sunitinib—pancreatic cancer	0.000296	0.00116	CcSEcCtD
Salicylate-sodium—Decreased appetite—Irinotecan—pancreatic cancer	0.000296	0.00116	CcSEcCtD
Salicylate-sodium—Arrhythmia—Docetaxel—pancreatic cancer	0.000295	0.00116	CcSEcCtD
Salicylate-sodium—Dyspnoea—Gemcitabine—pancreatic cancer	0.000295	0.00116	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000295	0.00115	CcSEcCtD
Salicylate-sodium—Somnolence—Gemcitabine—pancreatic cancer	0.000294	0.00115	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Epirubicin—pancreatic cancer	0.000294	0.00115	CcSEcCtD
Salicylate-sodium—Fatigue—Irinotecan—pancreatic cancer	0.000293	0.00115	CcSEcCtD
Salicylate-sodium—Paraesthesia—Fluorouracil—pancreatic cancer	0.000292	0.00114	CcSEcCtD
Salicylate-sodium—Pruritus—Sunitinib—pancreatic cancer	0.000292	0.00114	CcSEcCtD
Salicylate-sodium—Pain—Irinotecan—pancreatic cancer	0.000291	0.00114	CcSEcCtD
Salicylate-sodium—Constipation—Irinotecan—pancreatic cancer	0.000291	0.00114	CcSEcCtD
Salicylate-sodium—Dyspnoea—Fluorouracil—pancreatic cancer	0.00029	0.00114	CcSEcCtD
Salicylate-sodium—Somnolence—Fluorouracil—pancreatic cancer	0.000289	0.00113	CcSEcCtD
Salicylate-sodium—Erythema—Docetaxel—pancreatic cancer	0.000288	0.00113	CcSEcCtD
Salicylate-sodium—Decreased appetite—Gemcitabine—pancreatic cancer	0.000288	0.00113	CcSEcCtD
Salicylate-sodium—Dyspepsia—Fluorouracil—pancreatic cancer	0.000287	0.00112	CcSEcCtD
Salicylate-sodium—Nausea—Tamoxifen—pancreatic cancer	0.000286	0.00112	CcSEcCtD
Salicylate-sodium—Fatigue—Gemcitabine—pancreatic cancer	0.000286	0.00112	CcSEcCtD
Salicylate-sodium—Pain—Gemcitabine—pancreatic cancer	0.000283	0.00111	CcSEcCtD
Salicylate-sodium—Constipation—Gemcitabine—pancreatic cancer	0.000283	0.00111	CcSEcCtD
Salicylate-sodium—Nausea—Erlotinib—pancreatic cancer	0.000283	0.00111	CcSEcCtD
Salicylate-sodium—Decreased appetite—Fluorouracil—pancreatic cancer	0.000283	0.00111	CcSEcCtD
Salicylate-sodium—Diarrhoea—Sunitinib—pancreatic cancer	0.000282	0.00111	CcSEcCtD
Salicylate-sodium—Dysgeusia—Docetaxel—pancreatic cancer	0.000282	0.0011	CcSEcCtD
Salicylate-sodium—Abdominal distension—Epirubicin—pancreatic cancer	0.000281	0.0011	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Irinotecan—pancreatic cancer	0.00028	0.0011	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00028	0.00109	CcSEcCtD
Salicylate-sodium—Asthma—Epirubicin—pancreatic cancer	0.000279	0.00109	CcSEcCtD
Salicylate-sodium—Dysphagia—Epirubicin—pancreatic cancer	0.000279	0.00109	CcSEcCtD
Salicylate-sodium—Pain—Fluorouracil—pancreatic cancer	0.000278	0.00109	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000278	0.00109	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—pancreatic cancer	0.000278	0.00109	CcSEcCtD
Salicylate-sodium—Dizziness—Sunitinib—pancreatic cancer	0.000273	0.00107	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000273	0.00107	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000273	0.00107	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000272	0.00106	CcSEcCtD
Salicylate-sodium—Body temperature increased—Irinotecan—pancreatic cancer	0.000269	0.00105	CcSEcCtD
Salicylate-sodium—Abdominal pain—Irinotecan—pancreatic cancer	0.000269	0.00105	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000268	0.00105	CcSEcCtD
Salicylate-sodium—Bronchitis—Epirubicin—pancreatic cancer	0.000268	0.00105	CcSEcCtD
Salicylate-sodium—Vomiting—Sunitinib—pancreatic cancer	0.000262	0.00103	CcSEcCtD
Salicylate-sodium—Body temperature increased—Gemcitabine—pancreatic cancer	0.000262	0.00102	CcSEcCtD
Salicylate-sodium—Rash—Sunitinib—pancreatic cancer	0.00026	0.00102	CcSEcCtD
Salicylate-sodium—Dermatitis—Sunitinib—pancreatic cancer	0.00026	0.00102	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—pancreatic cancer	0.00026	0.00102	CcSEcCtD
Salicylate-sodium—Urticaria—Fluorouracil—pancreatic cancer	0.000259	0.00101	CcSEcCtD
Salicylate-sodium—Headache—Sunitinib—pancreatic cancer	0.000259	0.00101	CcSEcCtD
Salicylate-sodium—Syncope—Docetaxel—pancreatic cancer	0.000258	0.00101	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—pancreatic cancer	0.000258	0.00101	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—pancreatic cancer	0.000258	0.00101	CcSEcCtD
Salicylate-sodium—Body temperature increased—Fluorouracil—pancreatic cancer	0.000257	0.00101	CcSEcCtD
Salicylate-sodium—Palpitations—Docetaxel—pancreatic cancer	0.000254	0.000996	CcSEcCtD
Salicylate-sodium—Weight increased—Epirubicin—pancreatic cancer	0.000254	0.000993	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Docetaxel—pancreatic cancer	0.000253	0.000991	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Irinotecan—pancreatic cancer	0.00025	0.00098	CcSEcCtD
Salicylate-sodium—Convulsion—Docetaxel—pancreatic cancer	0.000249	0.000976	CcSEcCtD
Salicylate-sodium—Drowsiness—Epirubicin—pancreatic cancer	0.000249	0.000973	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—pancreatic cancer	0.000248	0.000971	CcSEcCtD
Salicylate-sodium—Chest pain—Docetaxel—pancreatic cancer	0.000245	0.00096	CcSEcCtD
Salicylate-sodium—Nausea—Sunitinib—pancreatic cancer	0.000245	0.00096	CcSEcCtD
Salicylate-sodium—Renal failure—Epirubicin—pancreatic cancer	0.000244	0.000956	CcSEcCtD
Salicylate-sodium—Asthenia—Irinotecan—pancreatic cancer	0.000244	0.000955	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00024	0.000939	CcSEcCtD
Salicylate-sodium—Asthenia—Gemcitabine—pancreatic cancer	0.000238	0.00093	CcSEcCtD
Salicylate-sodium—Confusional state—Docetaxel—pancreatic cancer	0.000237	0.000927	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000235	0.00092	CcSEcCtD
Salicylate-sodium—Oedema—Docetaxel—pancreatic cancer	0.000235	0.00092	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—pancreatic cancer	0.000235	0.000919	CcSEcCtD
Salicylate-sodium—Epistaxis—Epirubicin—pancreatic cancer	0.000234	0.000918	CcSEcCtD
Salicylate-sodium—Pruritus—Gemcitabine—pancreatic cancer	0.000234	0.000917	CcSEcCtD
Salicylate-sodium—Infection—Docetaxel—pancreatic cancer	0.000233	0.000914	CcSEcCtD
Salicylate-sodium—Diarrhoea—Irinotecan—pancreatic cancer	0.000233	0.00091	CcSEcCtD
Salicylate-sodium—Shock—Docetaxel—pancreatic cancer	0.000231	0.000905	CcSEcCtD
Salicylate-sodium—Pruritus—Fluorouracil—pancreatic cancer	0.00023	0.000902	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—pancreatic cancer	0.00023	0.0009	CcSEcCtD
Salicylate-sodium—Tachycardia—Docetaxel—pancreatic cancer	0.000229	0.000898	CcSEcCtD
Salicylate-sodium—Diarrhoea—Gemcitabine—pancreatic cancer	0.000227	0.000887	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—pancreatic cancer	0.000226	0.000885	CcSEcCtD
Salicylate-sodium—Dizziness—Irinotecan—pancreatic cancer	0.000225	0.00088	CcSEcCtD
Salicylate-sodium—Anorexia—Docetaxel—pancreatic cancer	0.000224	0.000877	CcSEcCtD
Salicylate-sodium—Hepatitis—Epirubicin—pancreatic cancer	0.000223	0.000873	CcSEcCtD
Salicylate-sodium—Diarrhoea—Fluorouracil—pancreatic cancer	0.000223	0.000872	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000222	0.000869	CcSEcCtD
Salicylate-sodium—Hypotension—Docetaxel—pancreatic cancer	0.00022	0.00086	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—pancreatic cancer	0.000217	0.000849	CcSEcCtD
Salicylate-sodium—Vomiting—Irinotecan—pancreatic cancer	0.000216	0.000846	CcSEcCtD
Salicylate-sodium—Dizziness—Fluorouracil—pancreatic cancer	0.000215	0.000843	CcSEcCtD
Salicylate-sodium—Rash—Irinotecan—pancreatic cancer	0.000214	0.000839	CcSEcCtD
Salicylate-sodium—Dermatitis—Irinotecan—pancreatic cancer	0.000214	0.000838	CcSEcCtD
Salicylate-sodium—Headache—Irinotecan—pancreatic cancer	0.000213	0.000834	CcSEcCtD
Salicylate-sodium—Paraesthesia—Docetaxel—pancreatic cancer	0.000211	0.000826	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—pancreatic cancer	0.000211	0.000826	CcSEcCtD
Salicylate-sodium—Vomiting—Gemcitabine—pancreatic cancer	0.000211	0.000824	CcSEcCtD
Salicylate-sodium—Dyspnoea—Docetaxel—pancreatic cancer	0.00021	0.00082	CcSEcCtD
Salicylate-sodium—Somnolence—Docetaxel—pancreatic cancer	0.000209	0.000818	CcSEcCtD
Salicylate-sodium—Rash—Gemcitabine—pancreatic cancer	0.000209	0.000817	CcSEcCtD
Salicylate-sodium—Dermatitis—Gemcitabine—pancreatic cancer	0.000209	0.000816	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—pancreatic cancer	0.000208	0.000814	CcSEcCtD
Salicylate-sodium—Headache—Gemcitabine—pancreatic cancer	0.000207	0.000812	CcSEcCtD
Salicylate-sodium—Vomiting—Fluorouracil—pancreatic cancer	0.000207	0.00081	CcSEcCtD
Salicylate-sodium—Dyspepsia—Docetaxel—pancreatic cancer	0.000207	0.00081	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—pancreatic cancer	0.000206	0.000808	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000205	0.000804	CcSEcCtD
Salicylate-sodium—Rash—Fluorouracil—pancreatic cancer	0.000205	0.000804	CcSEcCtD
Salicylate-sodium—Dermatitis—Fluorouracil—pancreatic cancer	0.000205	0.000803	CcSEcCtD
Salicylate-sodium—Decreased appetite—Docetaxel—pancreatic cancer	0.000204	0.0008	CcSEcCtD
Salicylate-sodium—Headache—Fluorouracil—pancreatic cancer	0.000204	0.000798	CcSEcCtD
Salicylate-sodium—Fatigue—Docetaxel—pancreatic cancer	0.000203	0.000793	CcSEcCtD
Salicylate-sodium—Nausea—Irinotecan—pancreatic cancer	0.000202	0.00079	CcSEcCtD
Salicylate-sodium—Constipation—Docetaxel—pancreatic cancer	0.000201	0.000787	CcSEcCtD
Salicylate-sodium—Pain—Docetaxel—pancreatic cancer	0.000201	0.000787	CcSEcCtD
Salicylate-sodium—Arrhythmia—Epirubicin—pancreatic cancer	0.000199	0.00078	CcSEcCtD
Salicylate-sodium—Nausea—Gemcitabine—pancreatic cancer	0.000197	0.00077	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000195	0.000764	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—pancreatic cancer	0.000194	0.00076	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Docetaxel—pancreatic cancer	0.000194	0.000758	CcSEcCtD
Salicylate-sodium—Nausea—Fluorouracil—pancreatic cancer	0.000193	0.000757	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—pancreatic cancer	0.000192	0.000753	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000192	0.000752	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—pancreatic cancer	0.000191	0.000749	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—pancreatic cancer	0.00019	0.000744	CcSEcCtD
Salicylate-sodium—Body temperature increased—Docetaxel—pancreatic cancer	0.000186	0.000727	CcSEcCtD
Salicylate-sodium—Abdominal pain—Docetaxel—pancreatic cancer	0.000186	0.000727	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—pancreatic cancer	0.000184	0.000722	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—pancreatic cancer	0.000183	0.000716	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—pancreatic cancer	0.00018	0.000703	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—pancreatic cancer	0.000177	0.000693	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—pancreatic cancer	0.000176	0.000689	CcSEcCtD
Salicylate-sodium—Syncope—Epirubicin—pancreatic cancer	0.000174	0.000682	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Docetaxel—pancreatic cancer	0.000173	0.000678	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—pancreatic cancer	0.000172	0.000672	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—pancreatic cancer	0.000171	0.000668	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—pancreatic cancer	0.000169	0.000663	CcSEcCtD
Salicylate-sodium—Asthenia—Docetaxel—pancreatic cancer	0.000169	0.00066	CcSEcCtD
Salicylate-sodium—Convulsion—Epirubicin—pancreatic cancer	0.000168	0.000659	CcSEcCtD
Salicylate-sodium—Pruritus—Docetaxel—pancreatic cancer	0.000166	0.000651	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—pancreatic cancer	0.000165	0.000647	CcSEcCtD
Salicylate-sodium—Anxiety—Epirubicin—pancreatic cancer	0.000165	0.000645	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—pancreatic cancer	0.000161	0.000631	CcSEcCtD
Salicylate-sodium—Diarrhoea—Docetaxel—pancreatic cancer	0.000161	0.000629	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—pancreatic cancer	0.00016	0.000626	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—pancreatic cancer	0.000159	0.000622	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—pancreatic cancer	0.000159	0.00062	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000159	0.00062	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000158	0.000618	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—pancreatic cancer	0.000157	0.000616	CcSEcCtD
Salicylate-sodium—Shock—Epirubicin—pancreatic cancer	0.000156	0.00061	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—pancreatic cancer	0.000156	0.000609	CcSEcCtD
Salicylate-sodium—Dizziness—Docetaxel—pancreatic cancer	0.000155	0.000608	CcSEcCtD
Salicylate-sodium—Tachycardia—Epirubicin—pancreatic cancer	0.000155	0.000606	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000153	0.0006	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—pancreatic cancer	0.000153	0.000599	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—pancreatic cancer	0.000152	0.000597	CcSEcCtD
Salicylate-sodium—Anorexia—Epirubicin—pancreatic cancer	0.000151	0.000591	CcSEcCtD
Salicylate-sodium—Vomiting—Docetaxel—pancreatic cancer	0.000149	0.000585	CcSEcCtD
Salicylate-sodium—Rash—Docetaxel—pancreatic cancer	0.000148	0.00058	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—pancreatic cancer	0.000148	0.00058	CcSEcCtD
Salicylate-sodium—Dermatitis—Docetaxel—pancreatic cancer	0.000148	0.000579	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—pancreatic cancer	0.000148	0.000579	CcSEcCtD
Salicylate-sodium—Headache—Docetaxel—pancreatic cancer	0.000147	0.000576	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—pancreatic cancer	0.000147	0.000574	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000147	0.000574	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—pancreatic cancer	0.000146	0.00057	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—pancreatic cancer	0.000144	0.000565	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—pancreatic cancer	0.000143	0.00056	CcSEcCtD
Salicylate-sodium—Paraesthesia—Epirubicin—pancreatic cancer	0.000142	0.000557	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000142	0.000555	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—pancreatic cancer	0.000141	0.000553	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—pancreatic cancer	0.000141	0.000552	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—pancreatic cancer	0.00014	0.000547	CcSEcCtD
Salicylate-sodium—Nausea—Docetaxel—pancreatic cancer	0.00014	0.000546	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—pancreatic cancer	0.00014	0.000546	CcSEcCtD
Salicylate-sodium—Decreased appetite—Epirubicin—pancreatic cancer	0.000138	0.000539	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—pancreatic cancer	0.000137	0.000536	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—pancreatic cancer	0.000137	0.000535	CcSEcCtD
Salicylate-sodium—Pain—Epirubicin—pancreatic cancer	0.000136	0.000531	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—pancreatic cancer	0.000136	0.000531	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—pancreatic cancer	0.000132	0.000515	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—pancreatic cancer	0.000131	0.000512	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—pancreatic cancer	0.000131	0.000511	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—pancreatic cancer	0.00013	0.00051	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00013	0.000507	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—pancreatic cancer	0.000129	0.000505	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—pancreatic cancer	0.000127	0.000499	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—pancreatic cancer	0.000126	0.000495	CcSEcCtD
Salicylate-sodium—Urticaria—Epirubicin—pancreatic cancer	0.000126	0.000493	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—pancreatic cancer	0.000125	0.000491	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—pancreatic cancer	0.000125	0.000491	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—pancreatic cancer	0.000125	0.00049	CcSEcCtD
Salicylate-sodium—Body temperature increased—Epirubicin—pancreatic cancer	0.000125	0.00049	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000121	0.000473	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00012	0.000469	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Epirubicin—pancreatic cancer	0.000117	0.000457	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—pancreatic cancer	0.000117	0.000456	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—pancreatic cancer	0.000116	0.000454	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—pancreatic cancer	0.000116	0.000454	CcSEcCtD
Salicylate-sodium—Asthenia—Epirubicin—pancreatic cancer	0.000114	0.000445	CcSEcCtD
Salicylate-sodium—Pruritus—Epirubicin—pancreatic cancer	0.000112	0.000439	CcSEcCtD
Salicylate-sodium—Diarrhoea—Epirubicin—pancreatic cancer	0.000108	0.000424	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000108	0.000423	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—pancreatic cancer	0.000105	0.000412	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—pancreatic cancer	0.000105	0.00041	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—pancreatic cancer	0.000104	0.000406	CcSEcCtD
Salicylate-sodium—Vomiting—Epirubicin—pancreatic cancer	0.000101	0.000394	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—pancreatic cancer	0.0001	0.000393	CcSEcCtD
Salicylate-sodium—Rash—Epirubicin—pancreatic cancer	9.99e-05	0.000391	CcSEcCtD
Salicylate-sodium—Dermatitis—Epirubicin—pancreatic cancer	9.98e-05	0.000391	CcSEcCtD
Salicylate-sodium—Headache—Epirubicin—pancreatic cancer	9.93e-05	0.000389	CcSEcCtD
Salicylate-sodium—Dizziness—Doxorubicin—pancreatic cancer	9.7e-05	0.00038	CcSEcCtD
Salicylate-sodium—Nausea—Epirubicin—pancreatic cancer	9.42e-05	0.000369	CcSEcCtD
Salicylate-sodium—Vomiting—Doxorubicin—pancreatic cancer	9.33e-05	0.000365	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—pancreatic cancer	9.25e-05	0.000362	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—pancreatic cancer	9.24e-05	0.000362	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—pancreatic cancer	9.19e-05	0.00036	CcSEcCtD
Salicylate-sodium—Nausea—Doxorubicin—pancreatic cancer	8.71e-05	0.000341	CcSEcCtD
